Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats-Reference-Cited by-同舟云学术

Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats

Published:2008-04-23 Issue:1 Volume:326 Page:41-50
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Conway James G.,Pink Heather,Bergquist Mandy L.,Han Bajin,Depee Scott,Tadepalli Sarva,Lin Peiyuan,Crumrine R. Christian,Binz Jane,Clark Richard L.,Selph Jeffrey L.,Stimpson Stephen A.,Hutchins Jeff T.,Chamberlain Stanley D.,Brodie Thomas A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor

2. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)

3. Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidate Tracers for Imaging Colony-Stimulating Factor 1 Receptor in Neuroinflammation with Positron Emission Tomography: Issues and Progress;ACS Pharmacology & Translational Science;2023-10-18

2. Synergistic Inhibition Guided Fragment-Linking Strategy and Quantitative Structure–Property Relationship Modeling To Design Inhalable Therapeutics for Asthma Targeting CSF1R;ACS Omega;2023-06-01

3. Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance;Immunologic Research;2022-10-21

4. CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple;Current Osteoporosis Reports;2022-10-05

5. Colony-stimulating factor 1 receptor signaling in the central nervous system and the potential of its pharmacological inhibitors to halt the progression of neurological disorders;Inflammopharmacology;2022-03-15